<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Q318 SCS Market Recap: On Track for Another Record Year

Posted by Anne Staylor on 1/21/19 10:17 AM

Q318 SCS MarketNew Products, Continued Demand Provide SCS Market Tailwinds

SmartTRAK reports that with new products providing a strong tailwind in Q318, the SCS market saw another quarter of strong double-digit growth in both the US and WW, positioning the market for another record year. 

Among the many topics covered in the Q318 SCS Market Recap are:

  • Market Overview
  • Abbott’s Slowdown Continues

  • What’s Next?
  • Boston Scientific Going Strong on WaveWriter

  • DBS Ramping Up
  • Medtronic Accelerates

  • Nevro’s Growth Decelerates
  • A Skeptical Wall Street

  • Strategies for Growth

  • Who’s Next?

  • Q318 Regulatory and Clinical Highlights

According to SmartTRAK, YTD in 2018, the US SCS market grew +21.1% vs the same time period in 2017 , while the WW SCS market reached...

Read the entire Q318 SCS Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info


Topics: Neuromodulation-Spinal Cord Stimulation, Q318 Market Recaps

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts